IDMED

What IDMED does

IDMED SAS is a privately held French medical device company founded in 2007 and headquartered in Marseille, France. The company develops, manufactures, and commercializes specialized monitoring devices for anesthesia, intensive care, and neuro-ophthalmology. Its portfolio is built on three proprietary technology platforms: quantitative pupillometry (NeuroLight and AlgiScan, using the PPI and QPi scoring systems), neuromuscular blockade monitoring via 3D acceleromyography and EMG sensors (ToFscan and WiTOF), and automated endotracheal cuff pressure regulation (CuffGuard). All products are CE-marked Class IIA (CE 0459), ISO 13485 certified, and designed for operating room and ICU use, with an emphasis on reusable accessories and no-calibration-required operation.

The company's revenue model is centered on hardware sales of monitoring devices to hospitals, ICUs, and healthcare facilities, distributed through a network of distributors in approximately 30 countries supplemented by direct sales in France and wholly-owned subsidiaries in the USA (IDMED Corp., established 2022) and Canada (IDMED Canada, established 2024). Pricing is quote-based and non-reimbursable under French social security, with sales supported by free product demonstrations, medical congress participation (e.g., SFAR), and clinical evidence-based marketing backed by an extensive bibliography of peer-reviewed publications. The go-to-motion is enterprise field sales targeting hospital procurement and clinical champions.

IDMED serves a diverse customer base of major hospital systems and university hospitals across France, the UK (NHS Trusts), Spain, Canada, and the broader EMEA and North American markets. The company maintains a lean team of 11-50 employees, is founder-led under CEO Thierry Bagnol, and operates with a closely-held capital structure (€26,433 registered capital) with no disclosed external institutional investment. Its competitive positioning rests on examiner-independent objective measurements, domain specialization in three niche monitoring segments, and a sustainability-oriented product design philosophy.

Name

IDMED

Legal name

IDMED SAS

Website

https://idmed.fr

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

IDMED is a French medical device company that develops and commercializes specialized monitoring devices—pupillometers (NeuroLight, AlgiScan), neuromuscular blockade monitors (ToFscan, WiTOF), and a cuff pressure controller (CuffGuard)—for anesthesia, intensive care, and neuro-ophthalmology applications in hospitals worldwide, sold through distributors in ~30 countries.

Ownership category

akta.pro rank

Product category

Medical Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts) (HLAHADAJ)

Keywords

• Medical monitoring devices
• Neuromuscular blockade monitoring
• Quantitative pupillometry systems
• Analgesia monitoring devices
• Anesthesia and ICU equipment

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Others

Revenue model

1. Medical Device Hardware Sales: IDMED generates revenue primarily through the sale of its medical monitoring hardware devices — ToFscan, WiTOF, AlgiScan, NeuroLight, and CuffGuard — to hospitals, intensive care units, and healthcare facilities worldwide through direct sales and distributor networks.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

IDMED develops and commercializes medical monitoring devices for anesthesia and intensive care using pupillometry, 3D acceleromyography (3D-AMG), and electromyography (EMG) technologies. Its core portfolio includes AlgiScan (analgesia monitor), NeuroLight (quantitative pupillometer), ToFscan and WiTOF (neuromuscular blockade monitors), and CuffGuard (automatic endotracheal tube cuff pressure controller). Products are sold globally to hospitals, ICUs, neuro-ophthalmology clinics, and research laboratories.

Product overview

IDMED develops and commercialises a portfolio of four core medical monitoring devices for anaesthesia and intensive care, complemented by dedicated accessories. AlgiScan and NeuroLight are pupillometry-based monitors: AlgiScan measures patient analgesia levels via the Pupillary Pain Index (PPI) score for use in OR and ICU, while NeuroLight provides quantitative pupillometry with the QPi score for neurological assessment, anisocoria detection, and prognostication after cardiac arrest. ToFscan and WiTOF are neuromuscular blockade (NMT) monitors using 3D acceleromyography: ToFscan is the primary wired/wireless monitor with a new AI-powered 'copilot' interface (Reliability Index, NMT trend curve, Anticipation Gauge), while WiTOF is the wireless standalone station variant. CuffGuard is an automatic cuff pressure controller for endotracheal tubes preventing VAP and tracheal injuries. Accessories include reusable/autoclavable eyecups for the pupillometers, wireless charging stations, and a range of 3D-AMG and EMG sensors for the NMT monitors. Products are sold worldwide through a distributor network.

Differentiator

Problem solved

Functional benefit

Brands

• AlgiScan: Analgesia monitor utilizing pupillometry technology for measuring patient's level of analgesia through pupillary dilation reflex.
• NeuroLight
• TOFscan
• WiTOF
• CuffGuard

Products and services

• AlgiScan Portable analgesia monitor for use in operating rooms and intensive care units. Uses pupillometry to deliver a Pupillary Pain Index (PPI) score reflecting the patient's analgesia-nociception balance, as well as Pupillary Reflex Dilation (PRD), pupil size, and Photomotor Reflex (PLR) measurements at 0.1 mm precision. For anesthesiologists and ICU clinicians.
• NeuroLight Portable quantitative pupillometer providing accurate, objective, and reproducible measurement of pupil size and pupillary light reactivity. Features the Quantitative Pupillometry Index (QPi) score with colour-coded interpretation, reusable autoclavable eyecups, barcode scanner for patient identification, and Bluetooth data transfer. For neurological assessment and prognostication in ICUs, neuro-ICUs, and emergency departments.
• ToFscan Neuromuscular blockade (NMT) monitor using 3D acceleromyography (3D-AMG) sensors with no calibration required. Monitors depth of neuromuscular blockade and recovery from intubation to extubation using TOF, PTC, DBS, Single Twitch, and Tetanus stimulation modes. The next-generation version includes Reliability Index with corrective guidance, NMT trend curve, Anticipation Gauge, Event markers, customisable alert zones, and supports both 3D-AMG and EMG sensor options. For anesthesiologists and operating room clinicians.
• WiTOF Wireless neuromuscular monitoring station — the first wireless NMT monitor using 3D acceleromyography. Provides real-time control of neuromuscular blockade depth with wireless sensors, impedance monitoring, coloured flash validation, and secure wireless communication algorithms. No calibration required. For anesthesiologists managing neuromuscular blockade in operating rooms.
• CuffGuard Automatic cuff pressure controller for endotracheal tube cuffs used during mechanical ventilation. Automatically regulates cuff pressure across 5–40 cm H2O with ±2 cm H2O accuracy to help prevent ventilator-associated pneumonia (VAP), tracheal injuries, aspiration of gastric fluids, and ineffective ventilation. Features audible and visual 360° alarms, auto-rotation display, 20-hour battery, and single-patient tubing with anti-bacterial filter. Manufactured in France, with French Care and French Fab labels. For ICU clinicians managing mechanically ventilated patients.

Quantifiable outcome

• Residual paralysis is still present in 1 in 4 patients on arrival in the recovery room when not using objective NMT monitoring
• +2 more outcomes

Named customers20 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered minor and core.

• ECOSYSTEMminorStrategic or Co-development PartnerECOSYSTEM is an eco-organization approved by the French energy transition agency for waste electrical equipment. IDMED maintains a contract with ECOSYSTEM for the collection and recycling of WEEE (Waste Electrical and Electronic Equipment), ensuring compliance with WEEE Directive targets for collection, recycling, and recovery.
• B&P EnvironnementminorStrategic or Co-development PartnerIDMED has a contract with B&P Environnement that organises the collection and recycling of production waste. All product manufacturing waste that can be recycled is sorted with bins available on premises.
• DHL Go Green / UPS Carbon NeutralminorStrategic or Co-development PartnerTransport of IDMED products is carried out by carriers (DHL Go Green, UPS carbon neutral) who have environmental responsibility policies to reduce CO2 emissions and offset carbon emissions.
• Canadian Healthcare Distribution PartnerscoreChannel Partner/ Reseller/ DistributorIDMED Canada has forged strong partnerships with leading Canadian healthcare companies specialising in Anaesthesia and Critical Care. Partners include North York General, CHUS Sherbrooke, Alberta Health Services, London Health Sciences Centre, Hamilton Health Sciences, Horizon Health Network, Kingston Health Sciences Centre, CIUSSS du Nord-de-l'Île-de-Montréal, and CIUSSS de l'Outaouais. These partners provide extensive clinical expertise and dedicated resources enabling exceptional customer service across Canada.
• Pramex International (USA)coreChannel Partner/ Reseller/ DistributorIDMED Corp., the US subsidiary, is registered c/o Pramex International at 1251 Avenue of the Americas, New York, NY 10020. Pramex International serves as the US registered agent and facilitates US market operations.
• ECOSYSTEM (WEEE compliance)minorStrategic or Co-development PartnerIDMED maintains a contract with ECOSYSTEM, an eco-organization approved by the French energy transition agency for waste electrical equipment, for WEEE compliance.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Baxter International: Baxter offers sedation and anesthesia delivery products (e.g., Sedaconda) and critical-care consumables that intersect with IDMED's ICU and anesthesia customer base.
• Drägerwerk: Dräger is a leading anesthesia and ventilation equipment manufacturer whose integrated monitoring platforms overlap with IDMED's anesthesia and ICU focus.
• Mindray: Mindray's BeneVision and ePM series offer multi-parameter OR/ICU monitoring at competitive price points, addressing the same hospital purchasing cycles as IDMED's specialty monitors.
• Philips: Philips offers IntelliVue and related anesthesia/ICU monitoring platforms that compete with IDMED's specialty monitors as part of broader hospital purchasing decisions.
• Masimo: Masimo provides advanced patient monitoring including SedLine EEG-based anesthesia depth monitoring and pulse oximetry, competing for the same OR/ICU monitoring budgets as IDMED.
• GE HealthCare: GE HealthCare's CARESCAPE patient monitoring portfolio includes anesthesia and ICU parameter monitoring that competes with IDMED's standalone monitors at multi-parameter accounts.
• Medtronic: Medtronic offers patient monitoring and historically NMT products within a broad anesthesia and critical-care portfolio, competing with IDMED through bundled capital sales to hospitals.

Direct peers

• NeurOptics: NeurOptics is the leading specialist in quantitative pupillometry with its NPi-300 device, directly competing with IDMED's NeuroLight in ICU and neurology assessment use cases.
• Blink Device Company: Blink Device Company (successor to the TOF-Watch line) sells TOF-Cuff and related neuromuscular transmission monitors, directly competing with IDMED's TOFscan and WiTOF in OR and ICU settings.

Others

• OSI Systems: OSI Systems, via its healthcare division, supplies patient monitoring and detection systems adjacent to IDMED's specialty anesthesia and ICU monitoring portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/IdmedNews
• YouTubeyoutube.com/channel/UC_KGG2eUoCiUOvLxiplOKxg
• Facebookfacebook.com/profile.php?id=100087269760737
• LinkedInlinkedin.com/company/idmed

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDMED